Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D M Zahm
Thymosin Beta 15A (TMSB15A) Is a Predictor of Chemotherapy Response in Triple-Negative Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer
Current Oncology
Oncology
Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment
Oncotarget
Oncology
ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
CREB3L1 as a Potential Biomarker Predicting Response of Triple Negative Breast Cancer to Doxorubicin-Based Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
A Multigene Predictor of Metastatic Outcome in Early Stage Hormone Receptor-Negative and Triple-Negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Triple-Negative Breast Cancer
Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides
JAMA Dermatology
Dermatology
Medicine
A Review of Triple-Negative Breast Cancer
Cancer Control
Medicine
Oncology
Hematology